January 20, 2003 BY HAND DELIVERY Barry I. Eisenstein, M.D. Executive Vice President, Research & Development Cubist Pharmaceuticals, Inc. 65 Hayden Avenue Lexington, MA 02421 RE: RETENTION LETTER Dear Barry: You are a highly valuable employee of...Retention Agreement • March 28th, 2003 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations
AMENDMENT NO. 2 to theManufacturing and Supply Agreement • March 28th, 2003 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations
CUBIST PHARMACEUTICALS INC. AGREEMENT FOR LEASEAgreement for Lease • March 28th, 2003 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations
January 20, 2003 BY HAND DELIVERY Oliver Fetzer, Ph.D. Senior Vice President, Corporate Development & Chief Business Officer Cubist Pharmaceuticals, Inc. 65 Hayden Avenue Lexington, MA 02421 RE: RETENTION LETTER Dear Oliver: You are a highly valuable...Retention Letter • March 28th, 2003 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.69 CUBIST PHARMACEUTICALS, INC. EMPLOYEE CONFIDENTIALITY AGREEMENT In consideration of my employment or continued employment by Cubist Pharmaceuticals, Inc. (together with any subsidiary of Cubist Pharmaceuticals, Inc., the "Company"), and...Employee Confidentiality Agreement • March 28th, 2003 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
February 25, 2003 BY HAND DELIVERY Dr. Scott M. Rocklage Chairman & CEO Cubist Pharmaceuticals, Inc. 65 Hayden Avenue Lexington, MA 02421 RE: TRANSITION AGREEMENT Dear Scott: This letter agreement documents the transition agreement between you and...Transition Agreement • March 28th, 2003 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
